AN2 Therapeutics (ANTX) Research & Development (2021 - 2026)
AN2 Therapeutics' Research & Development was $6.02 million in Q2 2026, up 88.1% from $3.2 million a year earlier but down 10.7% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Research & Development (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, AN2 Therapeutics' Research & Development was $26.64 million through Jun 30, 2026, up 8.4% year-over-year; for FY2025, it came in at $24.77 million, down 38.8% from FY2024.
- Research & Development shows a four-year compound annual growth rate of 11.3% (FY2021 to FY2025).
- In earlier years, Research & Development was $40.49 million in FY2024 (-26.2%), $54.87 million in FY2023 (+92.5%), $28.51 million in FY2022 (+76.5%) and $16.16 million in FY2021.
- Quarterly Research & Development has moved between $3.2 million (Q2 2025) and $14.92 million (Q4 2023) over five years.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 17.5%.
- The best year-over-year quarter for Research & Development over five years was Q1 2022 (growth of 241.6%); the worst was Q2 2025 (a decline of 73.7%).
- Per Business Quant data, ANTX's Research & Development in the three quarters before Q2 2026 was $6.74 million (Q1 2026), $6.88 million (Q4 2025) and $7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | AN2 Therapeutics | 181.91 Mn | 181.91 Mn | - | 6.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.02 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 6.88 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 7.69 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 8.29 Mn |
| Jun 30, 2024 | 12.15 Mn |
| Mar 31, 2024 | 14.66 Mn |
| Dec 31, 2023 | 14.92 Mn |
| Sep 30, 2023 | 14.43 Mn |
| Jun 30, 2023 | 13.54 Mn |
| Mar 31, 2023 | 11.99 Mn |
| Dec 31, 2022 | 8.75 Mn |
| Sep 30, 2022 | 7.43 Mn |
| Jun 30, 2022 | 6.70 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 5.31 Mn |
| Sep 30, 2021 | 5.35 Mn |
API Access
AN2 Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();